- Share this article
-
Share on twitter
-
Share on LinkedIn
-
Share on Facebook
-
Email to a friend
-
Print page
Published on: 13 July 2020
This statement is a response to new advice from the MHRA regarding use of cyproterone acetate and risk of meningioma.
Your download should start automatically. If not download directly.